Diede Fennema, Gareth J Barker, Owen O'Daly, Beata R Godlewska, Ewan Carr, Kimberley Goldsmith, Allan H Young, Jorge Moll, Roland Zahn
{"title":"Neural signatures of emotional biases predict clinical outcomes in difficult-to-treat depression.","authors":"Diede Fennema, Gareth J Barker, Owen O'Daly, Beata R Godlewska, Ewan Carr, Kimberley Goldsmith, Allan H Young, Jorge Moll, Roland Zahn","doi":"10.1017/dep.2024.6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Neural predictors underlying variability in depression outcomes are poorly understood. Functional MRI measures of subgenual cortex connectivity, self-blaming and negative perceptual biases have shown prognostic potential in treatment-naïve, medication-free and fully remitting forms of major depressive disorder (MDD). However, their role in more chronic, difficult-to-treat forms of MDD is unknown.</p><p><strong>Methods: </strong>Forty-five participants (n = 38 meeting minimum data quality thresholds) fulfilled criteria for difficult-to-treat MDD. Clinical outcome was determined by computing percentage change at follow-up from baseline (four months) on the self-reported Quick Inventory of Depressive Symptomatology (16-item). Baseline measures included self-blame-selective connectivity of the right superior anterior temporal lobe with an <i>a priori</i> Brodmann Area 25 region-of-interest, blood-oxygen-level-dependent <i>a priori</i> bilateral amygdala activation for subliminal sad vs happy faces, and resting-state connectivity of the subgenual cortex with an <i>a priori</i> defined ventrolateral prefrontal cortex/insula region-of-interest.</p><p><strong>Findings: </strong>A linear regression model showed that baseline severity of depressive symptoms explained 3% of the variance in outcomes at follow-up (<i>F</i>[3,34] = .33, <i>p</i> = .81). In contrast, our three pre-registered neural measures combined, explained 32% of the variance in clinical outcomes (<i>F</i>[4,33] = 3.86, <i>p =</i> .01).</p><p><strong>Conclusion: </strong>These findings corroborate the pathophysiological relevance of neural signatures of emotional biases and their potential as predictors of outcomes in difficult-to-treat depression.</p>","PeriodicalId":520433,"journal":{"name":"Research directions. Depression","volume":"1 ","pages":"e21"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11869767/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research directions. Depression","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1017/dep.2024.6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Neural predictors underlying variability in depression outcomes are poorly understood. Functional MRI measures of subgenual cortex connectivity, self-blaming and negative perceptual biases have shown prognostic potential in treatment-naïve, medication-free and fully remitting forms of major depressive disorder (MDD). However, their role in more chronic, difficult-to-treat forms of MDD is unknown.
Methods: Forty-five participants (n = 38 meeting minimum data quality thresholds) fulfilled criteria for difficult-to-treat MDD. Clinical outcome was determined by computing percentage change at follow-up from baseline (four months) on the self-reported Quick Inventory of Depressive Symptomatology (16-item). Baseline measures included self-blame-selective connectivity of the right superior anterior temporal lobe with an a priori Brodmann Area 25 region-of-interest, blood-oxygen-level-dependent a priori bilateral amygdala activation for subliminal sad vs happy faces, and resting-state connectivity of the subgenual cortex with an a priori defined ventrolateral prefrontal cortex/insula region-of-interest.
Findings: A linear regression model showed that baseline severity of depressive symptoms explained 3% of the variance in outcomes at follow-up (F[3,34] = .33, p = .81). In contrast, our three pre-registered neural measures combined, explained 32% of the variance in clinical outcomes (F[4,33] = 3.86, p = .01).
Conclusion: These findings corroborate the pathophysiological relevance of neural signatures of emotional biases and their potential as predictors of outcomes in difficult-to-treat depression.